 | Publications |
1999
Ricol D, Cappellen D, El Marjou A, Gil-Diez-de-Medina S, Girault JM, Yoshida T, Ferry
G, Tucker G, Poupon MF, Chopin D, Thiery JP, Radvanyi F. Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer. Oncogene. 1999 Dec 2;18(51):7234-43.
Hill BT, Fiebig HH, Waud WR, Poupon MF, Colpaert F, Kruczynski A. Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts. Eur J Cancer. 1999 Mar;35(3):512-20.
Miccoli L, Oudard S, Beurdeley-Thomas A, Dutrillaux B, Poupon MF. Effect of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide (PK11195), a specific ligand of the peripheral benzodiazepine receptor, on the lipid fluidity of mitochondria in human glioma cells. Biochem Pharmacol. 1999 Aug 15;58(4):715-21.
Pocard M, Middleton S, Northover J, Poupon MF. Value of human colonic cancer models by surgical cecal implantation in nude mice]. Ann Chir. 1999;53:227-32.
|
 |
 |
April 22-25, 2013 | Chicago, IL | BIO International Convention
|
 |
 |
April 6-10, 2013 | Washington, DC | Annual AACR meeting
|
 |
 |
XenTech Acknowledged in Deloitte’s 2012 Technology Fast 500™ EMEA for 2nd Year Running
|
 |
 |
March 14-15, 2013 I Bologna, Italy I Stefano Cairo will be attending the SIOPEL group Spring Meeting
|
 |
 |
March 9th 2013 I Barcelona I Olivier Déas is giving a lecture at the CONPO symposium
|
 |
 |
March 7-9, 2013 | Barcelona, Spain | CONPO symposium Breast, Colon, lung and Melanoma
|
 | |